metastasis<\/a>, with generally poor prognoses, making it a significant challenge in clinical treatment. By integrating and analyzing multiple public genomic databases, the research team found that the RTN4IP1 gene is highly expressed in triple-negative breast cancer tissues and cell lines. Its expression level is significantly associated with shorter patient survival and a higher risk of distant metastasis. To validate its function, the researchers conducted gene knockdown experiments in triple-negative breast cancer cells, demonstrating that downregulation of RTN4IP1 expression effectively inhibits the proliferation, invasion, and migration capabilities of cancer cells.<\/p>\nThe researchers further verified the pro-metastatic function of this protein in vivo using experimental animal models. Through tail vein injection to construct a lung metastasis model, the study found that although knocking down RTN4IP1 did not affect the number of micro-metastatic lesions formed by tumor cells in the lungs, it significantly inhibited the subsequent growth and volume expansion of these metastatic lesions. This indicates that RTN4IP1 primarily regulates the post-colonization growth stage of metastasis. At the mechanistic level, the study elucidated the pathway through which RTN4IP1 promotes metastasis by interfering with cellular energy metabolism.<\/p>\n
The protein is localized to mitochondria, and its functional loss leads to a significant decrease in the levels of the essential coenzyme NAD\u207a within cells. NAD\u207a is a key factor in maintaining the normal operation of two major energy metabolism pathways-glycolysis and mitochondrial oxidative phosphorylation. Its depletion collectively suppresses the cell’s energy supply and biosynthetic capacity, thereby weakening the metastatic potential of cancer cells. Using co-immunoprecipitation techniques, the researchers also confirmed that RTN4IP1 directly interacts with the mitochondrial adenylate kinase AK4 and that AK4 is an essential downstream effector molecule for its pro-metastatic function.<\/p>\n
The value of this study lies not only in identifying RTN4IP1 as a factor associated with poor prognosis in triple-negative breast cancer but, more importantly, in delineating a clear signaling axis from RTN4IP1-AK4 molecular interaction to NAD\u207a metabolic disruption, ultimately leading to cellular metabolic reprogramming and enhanced metastatic capacity. This provides multiple potential entry points for intervening in this pathway.<\/p>\n
Based on these findings, the study proposes future translational research directions, such as designing small molecule inhibitors targeting the predicted NAD(P)-binding pocket in the RTN4IP1 protein structure or developing intervention strategies to disrupt the RTN4IP1-AK4 protein interaction. These ideas lay the groundwork for pioneering new targeted therapy pathways for triple-negative breast cancer.<\/p>\n
Source:<\/p>\n
Journal reference:<\/p>\n
Han, C., et al. (2026). Mitochondrial matrix protein RTN4IP1 promotes the progression and metastasis of triple-negative breast cancer through metabolic reprogramming. Chinese Medical Journal. DOI: 10.1097\/cm9.0000000000004074.\u00a0https:\/\/www.ovid.com\/jnls\/cmj\/fulltext\/10.1097\/cm9.0000000000004074~mitochondrial-matrix-protein-rtn4ip1-promotes-the<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. It is characterized by the absence…\n","protected":false},"author":2,"featured_media":36902,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[1239,258,3169,56129,12358,256,1242,103,3175,61,29714,60,1357,496,25521,2168,3063,22953,9520,2682,14530,89,3066,1856,3067],"class_list":["post-591296","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-breast-cancer","tag-cancer","tag-cell","tag-endocrine","tag-estrogen","tag-gene","tag-genomic","tag-health","tag-hospital","tag-ie","tag-in-vivo","tag-ireland","tag-medicine","tag-metabolism","tag-metastasis","tag-molecule","tag-oncology","tag-progesterone","tag-proliferation","tag-protein","tag-receptor","tag-research","tag-surgery","tag-therapy","tag-tumor"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/591296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=591296"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/591296\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/36902"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=591296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=591296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=591296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}